Peritoneal involvement in acute pericarditis with polyserositis may mimic acute cholecystitis: a case report
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Acute pericarditis is an inflammatory disease of the pericardium that can exclusively affect the pericardium or extend and affect other serosae, including pleura and peritoneum. The involvement and dysregulation of the inflammasome, a protein complex responsible for the innate immune response, appear to be central in these forms of idiopathic pericarditis. This multi-district interest leads to considering recurrent pericarditis also as a possible systemic disease. Here, we report the case of a 56-year-old male with a negative past medical history who presented with dyspnea, chest and abdominal pain, and low-grade fever. Routine investigations and echocardiography were consistent with acute pericarditis; a chest X-ray revealed pleural effusion and an abdominal ultrasound detected modest peritoneal effusion and cholecystitis. The symptoms completely regressed within 24 hours of initiating therapy with non-steroidal anti-inflammatory drugs and colchicine. The pericardial, pleural, and peritoneal effusions, along with cholecystitis, regressed in the next 4 weeks. This is the first reported case in which pericarditis with polyserositis also involved the gallbladder in the inflammatory process. It appears that standard therapy for pericarditis was effective in inducing remission of the extracardiac inflammatory processes, further supporting the hypothesis of an autoinflammatory etiology for the cholecystic inflammatory process as well. Early identification of pericarditis with systemic involvement implies shorter hospitalization times and improved therapeutic classification of the patient, thereby reducing the likelihood of corticosteroid-dependent pericarditis and significantly lowering the risk of relapse.
How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.